Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2025-12-25 @ 3:29 AM
NCT ID:
NCT07023705
Eligibility Criteria:
Inclusion Criteria:
* Only patients with the results of full blood count and white blood cell differentiation, measured before the treatment of suspected PE.
* Patients underwent CT pulmonary angiography to confirm or exclude pulmonary embolism diagnosis.
Exclusion Criteria:
* Patient with history of any myeloproliferative disorder, myelofibrosis, Glanzmann thrombasthenia, May-Hegglin anomaly, Bernard-Soulier syndrome, suspicion of disseminated intravascular coagulation.
* Patient receiving any anticoagulant drug at a therapeutic dose.
* Patient with blood transfusion in the last 2 months.
* Patients with acute coronary syndrome, pulmonary edema.
* Patient on immunosuppressive drugs , Oral contraceptive pills .
* Patients with severe renal or hepatic disease.
* Patients with Stroke.
* Patients with malignancy.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT07023705
Study Brief:
Protocol Section:
NCT07023705